Source link : https://www.newshealth.biz/health-news/icis-associated-with-twofold-increased-psoriasis-risk/
TOPLINE: Patients with cancer who receive immune checkpoint inhibitors (ICIs) have more than twice the risk for developing psoriasis compared with those who receive other treatments. METHODOLOGY: Researchers conducted a nationwide cohort study using data from the Taiwan National Health Insurance database and the Taiwan Cancer Registry. A total of 135,230 patients with clinical stage […]
Author : News Health
Publish date : 2024-11-06 16:00:00
Copyright for syndicated content belongs to the linked Source.
inHealth